Amedeo Smart

Free Medical Literature Service




  Free Subscription

Articles published in
    May 2024
  1. JENKINS AJ, Ogle GD, Scibilia R, Schwarz P, et al
    People who need insulin are particularly vulnerable in disasters and conflicts.
    BMJ. 2024;385:q1109.
    >> Share

  2. BIDULKA P, Lugo-Palacios DG, Carroll O, O'Neill S, et al
    Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data.
    BMJ. 2024;385:e077097.
    >> Share

    April 2024
    Diabetes UK defends partnership with Slimming World in face of criticism.
    BMJ. 2024;385:q962.
    >> Share

  4. SIMMS-WILLIAMS N, Treves N, Yin H, Lu S, et al
    Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study.
    BMJ. 2024;385:e078242.
    >> Share

  5. NOLAN T
    The use of continuous glucose monitoring devices in non-diabetic adults ... and other research.
    BMJ. 2024;385:q859.
    >> Share

  6. SETHI J
    Breaking free from the stigma of diabetes.
    BMJ. 2024;385:q890.
    >> Share

    Barbados is in the grip of a diabetic foot amputation crisis.
    BMJ. 2024;385:q350.
    >> Share

  8. PASTERNAK B, Wintzell V, Hviid A, Eliasson B, et al
    Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study.
    BMJ. 2024;385:e078225.
    >> Share

    March 2024
    Charity calls for Scottish government to increase access to diabetes technology.
    BMJ. 2024;384:q755.
    >> Share

  10. MAHASE E
    Type 1 diabetes: Randox removes adverts after claims that it was using fear to sell genetic test.
    BMJ. 2024;384:q744.
    >> Share

  11. SAUL H, Deeney B, Swaithes L, Hounkpatin H, et al
    Even short periods of diabetes remission are linked to lower risk of heart attack and stroke.
    BMJ. 2024;384:q516.
    >> Share

  12. TANNE JH
    FDA approves first over-the-counter blood glucose monitor for diabetes.
    BMJ. 2024;384:q611.
    >> Share

  13. TANNE JH
    US food manufacturer can say that eating yogurt reduces risk of type 2 diabetes, says FDA.
    BMJ. 2024;384:q569.
    >> Share

    February 2024
  14. LANE MM, Gamage E, Du S, Ashtree DN, et al
    Ultra-processed food exposure and adverse health outcomes: umbrella review of epidemiological meta-analyses.
    BMJ. 2024;384:e077310.
    >> Share

  15. KIM KS, Hong S, Han K, Park CY, et al
    Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study.
    BMJ. 2024;384:e076388.
    >> Share

  16. BHALA N
    Liver steatosis linked to type 2 diabetes outcomes.
    BMJ. 2024;384:q309.
    >> Share

    January 2024
  17. YAO H, Zhang A, Li D, Wu Y, et al
    Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis.
    BMJ. 2024;384:e076410.
    >> Share

  18. SUBRAMANIAN S, Khan F, Hirsch IB
    New advances in type 1 diabetes.
    BMJ. 2024;384:e075681.
    >> Share

    Artificial pancreases for type 1 diabetes: Better access is "watershed moment"-but delivery is key.
    BMJ. 2024;384:q102.
    >> Share

    Fragmented care is failing people with type 1 diabetes related eating disorders, inquiry finds.
    BMJ. 2024;384:q178.
    >> Share

    Semaglutide reduces the absolute risk of major cardiovascular events by 1.5.
    BMJ. 2024;384:q53.
    >> Share

    December 2023
  22. COURCOULAS AP, Daigle CR, Arterburn DE
    Long term outcomes of metabolic/bariatric surgery in adults.
    BMJ. 2023;383:e071027.
    >> Share

  23. COHEN D
    GLP-1 receptor agonists: European drug regulator asks makers for evidence of self-harm.
    BMJ. 2023;383:2906.
    >> Share

  24. CHEN TK, Hoenig MP, Nitsch D, Grams ME, et al
    Advances in the management of chronic kidney disease.
    BMJ. 2023;383:e074216.
    >> Share

    November 2023
    Challenges in diabetes and obesity: five minutes with . . . Jonathan Valabhji.
    BMJ. 2023;383:p2831.
    >> Share

    England's diabetes prevention programme has delivered causal benefits, study reports.
    BMJ. 2023;383:p2691.
    >> Share

  27. MAHASE E
    NICE recommends hybrid closed loop systems for poorly controlled type 1 diabetes.
    BMJ. 2023;383:p2619.
    >> Share

    October 2023
  28. KAR P
    Partha Kar: The time to tackle rising type 2 diabetes is T2DaY.
    BMJ. 2023;383:p2490.
    >> Share

  29. LEE YJ, Hong SJ, Kang WC, Hong BK, et al
    Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial.
    BMJ. 2023;383:e075837.
    >> Share

  30. LADHER N, Hinton R, Veitch E
    Challenges of obesity and type 2 diabetes require more attention to food environment.
    BMJ. 2023;383:p2269.
    >> Share

    September 2023
  31. WILL EJ
    SGLT2 inhibitors: here we go again?
    BMJ. 2023;382:2172.
    >> Share

  32. Diagnosis and management of diabetes in children and young people: summary of updated NICE guidance.
    BMJ. 2023;382:p2072.
    >> Share

  33. FOU L, Agwu JC, Aswani N, Bakhai C, et al
    Glucose monitoring and glucose lowering agents for children and young people with type 2 diabetes: summary of updated NICE guidance.
    BMJ. 2023;382:p1686.
    >> Share

  34. MAHASE E
    Tirzepatide: NICE recommends another GLP-1 agonist for type 2 diabetes.
    BMJ. 2023;382:2074.
    >> Share

    Diabetes: Doctors are told not to start new patients on GLP-1 agonists because of shortages.
    BMJ. 2023;382:2019.
    >> Share

    July 2023
    Risk of diabetes with statins: comparing apples with oranges.
    BMJ. 2023;382:p1720.
    >> Share

    UK clinics told to stop prescribing antidiabetes drugs for weight loss, after shortages.
    BMJ. 2023;382:1693.
    >> Share

  38. HANNA F, Wu P, Heald A, Fryer A, et al
    Diabetes detection in women with gestational diabetes and polycystic ovarian syndrome.
    BMJ. 2023;382:e071675.
    >> Share

    June 2023
  39. MAHASE E
    Tackling structural racism is crucial to ending global diabetes crisis, researchers say.
    BMJ. 2023;381:p1439.
    >> Share

  40. WISE J
    Covid-19: Metformin reduces the risk of developing long term symptoms by 40%, study finds.
    BMJ. 2023;381:p1306.
    >> Share

    May 2023
  41. GRAY M
    Preventing type 2 diabetes: public health campaigns should focus on living longer better.
    BMJ. 2023;381:p1139.
    >> Share

  42. MANSI IA, Sumithran P, Kinaan M
    Risk of diabetes with statins.
    BMJ. 2023;381:e071727.
    >> Share

    Diabetes: Missed routine checks are causing premature deaths in England, charity warns.
    BMJ. 2023;381:1070.
    >> Share

  44. WHITE SL, Ayman G, Bakhai C, Hillier TA, et al
    Screening and diagnosis of gestational diabetes.
    BMJ. 2023;381:e071920.
    >> Share

    April 2023
  45. VALABHJI J, Kar P
    Rise in type 2 diabetes shows that prevention is more important than ever.
    BMJ. 2023;381:p910.
    >> Share

  46. Rise in type 2 diabetes shows that prevention is more important than ever.
    BMJ. 2023;381:p941.
    >> Share

  47. SAUL H, Deeney B, Imison C, Tesfaye S, et al
    Combination therapy for painful diabetic neuropathy is safe and effective.
    BMJ. 2023;381:p866.
    >> Share

  48. MA L, Hu Y, Alperet DJ, Liu G, et al
    Beverage consumption and mortality among adults with type 2 diabetes: prospective cohort study.
    BMJ. 2023;381:e073406.
    >> Share

    Beverages and health outcomes in adults with type 2 diabetes.
    BMJ. 2023;381:p841.
    >> Share

  50. LYU H, Zhao SS, Zhang L, Wei J, et al
    Denosumab and incidence of type 2 diabetes among adults with osteoporosis: population based cohort study.
    BMJ. 2023;381:e073435.
    >> Share

  51. WISE J
    Diabetes cases in UK reach all time high, charity warns.
    BMJ. 2023;381:p848.
    >> Share

  52. SHI Q, Nong K, Vandvik PO, Guyatt GH, et al
    Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials.
    BMJ. 2023;381:e074068.
    >> Share

    March 2023
    Semaglutide: should the media slim down its enthusiasm?
    BMJ. 2023;380:p624.
    >> Share

  54. WISE J
    Novo Nordisk suspended from industry body over serious breaches.
    BMJ. 2023;380:p634.
    >> Share

    February 2023
  55. CRUMP C, Sundquist J, McLaughlin MA, Dolan SM, et al
    Adverse pregnancy outcomes and long term risk of ischemic heart disease in mothers: national cohort and co-sibling study.
    BMJ. 2023;380:e072112.
    >> Share

    January 2023
    Type 1 diabetes: NICE recommends new "artificial pancreas" technology.
    BMJ. 2023;380:p55.
    >> Share

    December 2022
  57. XIE J, Wang M, Long Z, Ning H, et al
    Global burden of type 2 diabetes in adolescents and young adults, 1990-2019: systematic analysis of the Global Burden of Disease Study 2019.
    BMJ. 2022;379:e072385.
    >> Share

    November 2022
  58. TAYLOR L
    Diabetes prevalence in Americas tripled in 30 years.
    BMJ. 2022;379:o2868.
    >> Share

    Type 1 diabetes: US approves drug that can delay onset.
    BMJ. 2022;379:o2798.
    >> Share

  60. PRADHAN R, Lu S, Yin H, Yu OHY, et al
    Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based cohort study.
    BMJ. 2022;379:e071380.
    >> Share

    October 2022
  61. MULVIHILL C, Brooks A, Basudev N, Lincoln P, et al
    Continuous glucose monitoring for adults and children with diabetes: summary of updated NICE guidance.
    BMJ. 2022;379:o2418.
    >> Share

  62. HUANG C, Wei K, Lee PMY, Qin G, et al
    Maternal hypertensive disorder of pregnancy and mortality in offspring from birth to young adulthood: national population based cohort study.
    BMJ. 2022;379:e072157.
    >> Share

  63. IKOMI AE
    It's time to widen the capture of gestational diabetes in the UK.
    BMJ. 2022;379:o2444.
    >> Share

  64. DENG Y, Polley EC, Wallach JD, Dhruva SS, et al
    Emulating the GRADE trial using real world data: retrospective comparative effectiveness study.
    BMJ. 2022;379:e070717.
    >> Share

    September 2022
  65. MAHASE E
    Type 1 diabetes: Global prevalence is set to double by 2040, study estimates.
    BMJ. 2022;378:o2289.
    >> Share

  66. YANG J, Qian F, Chavarro JE, Ley SH, et al
    Modifiable risk factors and long term risk of type 2 diabetes among individuals with a history of gestational diabetes mellitus: prospective cohort study.
    BMJ. 2022;378:e070312.
    >> Share

  67. XIE W, Wang Y, Xiao S, Qiu L, et al
    Association of gestational diabetes mellitus with overall and type specific cardiovascular and cerebrovascular diseases: systematic review and meta-analysis.
    BMJ. 2022;378:e070244.
    >> Share

    August 2022
    The failed promise of the US's Inflation Reduction Act for patients with diabetes.
    BMJ. 2022;378:o2086.
    >> Share

    NHS to rollout continuous glucose monitors for all patients with type 1 diabetes.
    BMJ. 2022;378:o1935.
    >> Share

    July 2022
  70. WISE J
    Covid-19: Infection raises risk of diabetes and heart disease diagnoses in following weeks, study finds.
    BMJ. 2022;378:o1838.
    >> Share

    June 2022
  71. HE L, Wang J, Ping F, Yang N, et al
    Dipeptidyl peptidase-4 inhibitors and gallbladder or biliary disease in type 2 diabetes: systematic review and pairwise and network meta-analysis of randomised controlled trials.
    BMJ. 2022;377:e068882.
    >> Share

  72. WISE J
    Type 2 diabetes: Charity warns of "perfect storm" putting more children at risk.
    BMJ. 2022;377:o1451.
    >> Share

  73. WISE J
    Diabetes drug results in substantial weight loss in people with obesity, study finds.
    BMJ. 2022;377:o1406.
    >> Share

    May 2022

  74. Vitamin D and risk of type 2 diabetes.
    BMJ. 2022;377:o1326.
    >> Share

  75. YE W, Luo C, Huang J, Li C, et al
    Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis.
    BMJ. 2022;377:e067946.
    >> Share

  76. KAWAHARA T, Suzuki G, Mizuno S, Inazu T, et al
    Effect of active vitamin D treatment on development of type 2 diabetes: DPVD randomised controlled trial in Japanese population.
    BMJ. 2022;377:e066222.
    >> Share

    Vitamin D and risk of type 2 diabetes.
    BMJ. 2022;377:o1166.
    >> Share

    Managing type 1 diabetes: have faith in patients.
    BMJ. 2022;377:o1240.
    >> Share

  79. ARMSTRONG GRAY T, Hussain S, Gray M
    Empower young people with type 1 diabetes.
    BMJ. 2022;377:o1237.
    >> Share

  80. MORAN GM, Bakhai C, Song SH, Agwu JC, et al
    Type 2 diabetes: summary of updated NICE guidance.
    BMJ. 2022;377:o775.
    >> Share

    April 2022

  81. SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline.
    BMJ. 2022;377:o1080.
    >> Share

  82. SAUL H, Gursul D, Cassidy S, Sharpe D, et al
    Why don't children and young people engage with diabetes services?
    BMJ. 2022;377:o750.
    >> Share

  83. NG SM, Corbett T, Doble E, Brooks A, et al
    Managing the psychosocial impact of type 1 diabetes in young people.
    BMJ. 2022;377:e070530.
    >> Share

    March 2022
    All patients with type 1 diabetes in England should be offered continuous glucose monitoring, says NICE.
    BMJ. 2022;376:o834.
    >> Share

  85. DYER C
    Young man who refused treatment for suspected type 1 diabetes died before palliative care plan was put in place.
    BMJ. 2022;376:o787.
    >> Share

  86. HODKINSON A, Tsimpida D, Kontopantelis E, Rutter MK, et al
    Comparative effectiveness of statins on non-high density lipoprotein cholesterol in people with diabetes and at risk of cardiovascular disease: systematic review and network meta-analysis.
    BMJ. 2022;376:e067731.
    >> Share

    February 2022
  87. MAHASE E
    Type 1 diabetes drug was withdrawn because of a "commercial conflict of interest," charity argues.
    BMJ. 2022;376:o373.
    >> Share

  88. TANNE JH
    Diabetes kills 100 000 Americans for second year in a row.
    BMJ. 2022;376:o300.
    >> Share

    January 2022
  89. MAHMOOD A, Dar S, Dabhad A, Aksi B, et al
    Advising patients with existing conditions about fasting during Ramadan.
    BMJ. 2022;376:e063613.
    >> Share

  90. Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials.
    BMJ. 2022;376:o109.
    >> Share

  91. JAYEDI A, Soltani S, Motlagh SZ, Emadi A, et al
    Anthropometric and adiposity indicators and risk of type 2 diabetes: systematic review and dose-response meta-analysis of cohort studies.
    BMJ. 2022;376:e067516.
    >> Share

  92. SLUGGETT JK, Rigby D
    Simplifying medications for people with type 2 diabetes.
    BMJ. 2022;376:n3158.
    >> Share

    December 2021
  93. GAHUNGU N, Trueick R, Coopes M, Gabbay E, et al
    Paroxysmal atrial fibrillation.
    BMJ. 2021;375:e058568.
    >> Share

  94. BESSER REJ, Ng SM, Robertson EJ
    Screening children for type 1 diabetes.
    BMJ. 2021;375:e067937.
    >> Share

    November 2021
  95. NOLAN T
    Tom Nolan's research reviews-26 November 2021.
    BMJ. 2021;375:n2938.
    >> Share

  96. AUBERT CE, Lega IC, Bourron O, Train AJ, et al
    When and how to deintensify type 2 diabetes care.
    BMJ. 2021;375:e066061.
    >> Share

    October 2021
    One in 10 UK adults could have diabetes by 2030, warns charity.
    BMJ. 2021;375:n2453.
    >> Share

    September 2021
  98. SLIEKER RC, van der Heijden AAWA, Siddiqui MK, Langendoen-Gort M, et al
    Performance of prediction models for nephropathy in people with type 2 diabetes: systematic review and external validation study.
    BMJ. 2021;374:n2134.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016